Skip to main navigation Skip to main content
  • E-Submission
  • Contact us

NS : Neurospine

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Page Path

Original Article

Outcomes of Transforaminal Lumbar Interbody Fusion Using Unilateral Versus Bilateral Interbody Cages

Neurospine 2021;18(4):854-862.
Published online: December 31, 2021

Department of Orthopaedic Surgery, Rush University Medical Center, Chicago, IL, USA

Corresponding Author Kern Singh https://orcid.org/0000-0002-6118-7273 Department of Orthopaedic Surgery, Rush University Medical Center, 1611 W. Harrison St, Suite #300 Chicago, IL 60612, USA Email: kern.singh@rushortho.com
• Received: March 3, 2021   • Revised: March 20, 2021   • Accepted: March 28, 2021

Copyright © 2021 by the Korean Spinal Neurosurgery Society

This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 9,383 Views
  • 146 Download
  • 16 Web of Science
  • 18 Crossref
  • 18 Scopus
prev next

Citations

Citations to this article as recorded by  Crossref logo
  • Impact of nonunion on patient-related outcomes after single level minimally invasive transforaminal lumbar interbody fusion for lumbar degenerative disease: A propensity score–matched analysis
    Tatsuya Yamamoto, Momotaro Kawai, Tomohisa Tabata, Yohei Takahashi, Jun Ogawa
    European Spine Journal.2026; 35(4): 1736.     CrossRef
  • Comparative outcomes of unilateral and bilateral cage placement in lumbar interbody fusion: a systematic review and meta-analysis of randomized controlled trials
    Stavros Stamiris, Dimitrios Stamiris, Elissavet Anestiadou, Athanasios Sarridimitriou, Angeliki Cheva, Antonia Loukousia, Vasilleios Vrangalas, Pavlos Christodoulou, Christos Karampalis
    Asian Spine Journal.2026; 20(2): 372.     CrossRef
  • Is there a difference in unilateral versus bilateral facetectomy in an open or minimally invasive surgery transforaminal lumbar interbody fusion? A systematic review and meta-analysis
    Mario Cyriac Tchaya Tcheukado, George Nageeb, Jonathan Hintz, Michael Steinmetz, Mohamed Macki
    Surgical Neurology International.2026; 17: 110.     CrossRef
  • Comparative analysis of single vs. double cage insertion in unilateral biportal endoscopic lumbar interbody fusion: clinical and radiological outcomes
    Guisi Xie, Yanli Pan, Zhongshu Shan, Chan Wang Lei, Lek Hang Cheang, Jiaming Liang, Junfeng Shen, Wei Zhang, Chengyue Zhu
    Frontiers in Surgery.2026;[Epub]     CrossRef
  • Letter re: Letter to the Editor Concerning ‘Long-Term Incidence of Adjacent Segmental Pathology after Minimally Invasive vs. Open Transforaminal Lumbar Interbody Fusion’
    Sitian Niu, Ranran Li, Jingzhi Wang
    Global Spine Journal.2025; 15(2): 1459.     CrossRef
  • Long-Term Incidence of Adjacent Segmental Pathology After Minimally Invasive vs Open Transforaminal Lumbar Interbody Fusion
    Jae-Won Shin, Yung Park, Sang-Ho Kim, Sung-Ryul Choi, Joong-Won Ha, Hak Sun Kim, Kyung-Soo Suk, Sung-Hwan Moon, Si-Young Park, Byung-Ho Lee, Ji-Won Kwon, Hee-Min Choi
    Global Spine Journal.2025; 15(2): 1457.     CrossRef
  • Cost-effectiveness analysis of extended endoscopic lumbar foraminotomy (EELF) and transforaminal lumbar interbody fusion (TLIF): a prospective observational study
    Jun-Hoe Kim, Hangeul Park, Chang-Hyun Lee, Chi Heon Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Long-Term Risk of Adjacent-Segment Disease in Isthmic Spondylolisthesis Treated with Posterior Interbody Fusion
    Delia Cannizzaro, Gabriele Capo, Matteo Gionso, Donato Creatura, Mario De Robertis, Carla Daniela Anania, Emanuele Stucchi, Emilia Bellina, Ali Baram, Carlo Brembilla, Massimo Tomei, Alessandro Ortolina, Emanuela Morenghi, Franco Servadei, Federico Pessin
    World Neurosurgery.2025; 196: 123822.     CrossRef
  • Biomechanical Comparison of Transforaminal Interbody Fusion Implants: Static vs Expandable Cages and Unilateral Versus Bilateral Cages
    Clayton L. Rosinski, Nicole A. D. Watson, Michael E. Kritikos, Kirill V. Nourski, Anthony J. Marincovich, Tyson S. Matern, Prabin Shrestha, Patrick W. Hitchon
    Operative Neurosurgery.2025;[Epub]     CrossRef
  • Unilateral Versus Bilateral Cages in Lumbar Interbody Fusions: A Meta-Analysis of Clinical and Radiographic Outcomes
    Mohammad Daher, Marven Aoun, Pierre El-Sett, Gaby Kreichati, Khalil Kharrat, Amer Sebaaly
    World Neurosurgery.2024; 186: 158.     CrossRef
  • An evaluation of fusion status following lumbar fusion surgery utilizing multi-planar computed tomography
    Tariq Z. Issa, Yunsoo Lee, Jeremy Heard, Tyler W. Henry, Michael A. McCurdy, Nicholas Siegel, Caroline Zaworksi, Julia Dambly, Jose A. Canseco, Alan S. Hilibrand, Alexander R. Vaccaro, Gregory D. Schroeder, John Mangan, Mark Lambrechts, Christopher K. Kep
    European Spine Journal.2024; 33(9): 3545.     CrossRef
  • Postoperative urinary retention after oblique lumbar interbody fusion under the systematic management protocol
    Joonsoo Lim, Jangyeob Lim, Asfandyar Khan, Chang-Hyun Lee, Jun-Hoe Kim, Sejin Choi, Tae-Shin Kim, Yunhee Choi, Chun Kee Chung, Sangwook T. Yoon, Kyoung-Tae Kim, Chi Heon Kim
    Scientific Reports.2024;[Epub]     CrossRef
  • Commentary on “Three-Dimensional-Printed Titanium Versus Polyetheretherketone Cages for Lumbar Interbody Fusion: A Systematic Review of Comparative In Vitro, Animal, and Human Studies”
    Yanting Liu, Siravich Suvithayasiri, Jin-Sung Kim
    Neurospine.2023; 20(2): 464.     CrossRef
  • Comparison of Lumbosacral Fusion Grade in Patients after Transforaminal and Anterior Lumbar Interbody Fusion with Minimum 2‐Year Follow‐Up
    Jinping Liu, Rong Xie, Cynthia T. Chin, Priya Rajagopalan, Ping‐Guo Duan, Bo Li, Shane Burch, Sigurd H. Berven, Praveen V. Mummaneni, Dean Chou
    Orthopaedic Surgery.2023; 15(9): 2334.     CrossRef
  • A Comparison of Radiographic Alignment between Bilateral and Unilateral Interbody Cages in Patients Undergoing Transforaminal Lumbar Interbody Fusion
    Mark James Lambrechts, Jeremy Heard, Nicholas D’Antonio, John Bodnar, Gregory Schneider, Evan Bloom, Jose Canseco, Barrett Woods, Ian David Kaye, Mark Kurd, Jeffrey Rihn, Alan Hilibrand, Gregory Schroeder, Alexander Vaccaro, Christopher Kepler
    Asian Spine Journal.2023; 17(4): 666.     CrossRef
  • Morphometric Comparison of Interbody Fusion with Cage and Autograft at L4-L5 Levels versus Autograft Alone for Fusion
    Azmi Tufan, Feyza Karagöz Güzey, Abdurrahman Aycan
    Bagcilar Medical Bulletin.2023; 8(3): 293.     CrossRef
  • Lumbar interbody fusion with bilateral cages using a biportal endoscopic technique with a third portal
    Chengyue Zhu, Liangping Zhang, Hao Pan, Wei Zhang
    Acta Neurochirurgica.2022; 164(9): 2343.     CrossRef
  • Safety and efficacy of unilateral and bilateral pedicle screw fixation for lumbar degenerative diseases by transforaminal lumbar interbody fusion: An updated systematic review and meta-analysis
    Rui Zhong, Xiali Xue, Runsheng Wang, Jing Dan, Chuanen Wang, Daode Liu
    Frontiers in Neurology.2022;[Epub]     CrossRef

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Outcomes of Transforaminal Lumbar Interbody Fusion Using Unilateral Versus Bilateral Interbody Cages
Neurospine. 2021;18(4):854-862.   Published online December 31, 2021
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Outcomes of Transforaminal Lumbar Interbody Fusion Using Unilateral Versus Bilateral Interbody Cages
Neurospine. 2021;18(4):854-862.   Published online December 31, 2021
Close
Outcomes of Transforaminal Lumbar Interbody Fusion Using Unilateral Versus Bilateral Interbody Cages
Outcomes of Transforaminal Lumbar Interbody Fusion Using Unilateral Versus Bilateral Interbody Cages
Demographic Unilateral cage (n = 111) Bilateral cages (n = 40) p-value
Age (yr) 53.1 ± 11.4 49.2 ± 10.5 0.058
Sex 0.538
 Female 45 (40.5) 14 (35.0)
 Male 66 (59.5) 26 (65.0)
Body mass index (kg/m2) 0.554
 < 30 55 (49.6) 22 (55.0)
 ≥ 30 56 (50.5) 18 (45.0)
Smoking status 0.339
 Nonsmoker 93 (83.8) 36 (90.0)
 Smoker 18 (16.2) 4 (10.0)
Diabetes 0.041*
 Nondiabetic 95 (85.9) 39 (97.5)
 Diabetic 16 (14.4) 2.5 (1
ASA PS classification grade 2.1 ± 0.5 2.0 ± 0.5 0.242
CCI score 2.0 ± 1.5 1.2 ± 1.1 0.003*
Insurance 0.010*
 Medicare/medicaid 11 (9.9) 0 (0)
 Workers’ compensation 45 (40.5) 10 (25.0)
 Private 55 (49.6) 30 (75.0)
Characteristic Unilateral cage (n = 111) Bilateral cages (n = 40) p-value
Spinal pathology
 Recurrent herniated nucleus pulposus 9 (8.1) 2 (5.0) 0.517
 Degenerative spondylolisthesis 57 (51.4) 9 (22.5) 0.002*
 Isthmic spondylolisthesis 24 (21.6) 28 (70.0) < 0.001*
Fusion level 0.003*
 L3/L4 3 (2.7) 0 (0)
 L4/L5 59 (53.2) 10 (25.0)
 L5/S1 49 (44.1) 30 (75.0)
Bone graft 0.069
 BMP-2 97 (87.4) 34 (85.0)
 Iliac crest bone graft 1 (0.9) 3 (7.5)
 Other 13 (11.7) 3 (7.5)
Operative time (min) 138.3 ± 33.3 143.2 ± 32.1 0.429
Estimated blood loss (mL) 64.0 ± 32.0 66.9 ± 51.4 0.680
Length of stay (hr) 56.3 ± 32.1 43.2 ± 21.8 0.022*
Arthrodesis by 1 year 0.035*
 Nonunion 12 (11.0) 0 (0)
 Solid fusion 97 (89.0) 37 (100)
PROM Unilateral cage Bilateral cages p-value p-value
VAS back
 Preoperative 6.8 ± 2.1 6.8 ± 2.4 0.932
 6 Weeks (Δ) 2.8 ± 2.7 2.4 ± 3.4 0.487 0.551
 12 Weeks (Δ) 3.0 ± 2.8 3.6 ± 3.0 0.282 0.888
 6 Months (Δ) 3.2 ± 2.9 4.0 ± 3.1 0.226 0.277
 1 Year (Δ) 3.1 ± 2.4 3.9 ± 3.1 0.352 0.412
 2 Years (Δ) 3.7 ± 3.1 2.9 ± 4.6 0.606 0.212
VAS leg
 Preoperative 6.1 ± 2.5 4.6 ± 3.2 0.017*
 6 Weeks (Δ) 3.1 ± 3.4 2.0 ± 4.1 0.214 0.995
 12 Weeks (Δ) 3.0 ± 2.8 2.3 ± 3.5 0.308 0.805
 6 Months (Δ) 3.3 ± 2.8 2.0 ± 3.1 0.084 0.393
 1 Year (Δ) 3.9 ± 2.9 2.8 ± 2.5 0.199 0.054
 2 Years (Δ) 3.8 ± 3.1 3.0 ± 3.4 0.547 0.380
ODI
 Preoperative 45.1 ± 17.2 39.6 ± 15.6 0.145
 6 Weeks (Δ) 7.9 ± 17.4 4.9 ± 21.7 0.511 0.259
 12 Weeks (Δ) 13.2 ± 16.3 17.4 ± 17.8 0.296 0.615
 6 Months (Δ) 17.7 ± 15.3 18.3 ± 22.2 0.888 0.930
 1 Year (Δ) 19.0 ± 17.5 18.4 ± 14.6 0.915 0.412
 2 Years (Δ) 25.8 ± 23.5 8.2 ± 29.6 0.118 0.026*
SF-12 PCS
 Preoperative 30.0 ± 9.0 34.9 ± 12.4 0.045*
 6 Weeks (Δ) 0.9 ± 9.4 -0.4 ± 8.4 0.642 0.666
 12 Weeks (Δ) 7.2 ± 9.4 10.8 ± 11.4 0.307 0.611
 6 Months (Δ) 9.8 ± 12.0 12.9 ± 12.4 0.469 0.663
 1 Year (Δ) 13.6 ± 9.8 9.8 ± 8.3 0.212 0.170
 2 Years (Δ) 11.9 ± 11.3 7.4 ± 11.1 0.289 0.253
PROMIS-PF
 Preoperative 34.0 ± 5.6 37.0 ± 4.7 0.165
 6 Weeks (Δ) 1.4 ± 5.3 -0.2 ± 6.2 0.556 0.108
 12 Weeks (Δ) 2.9 ± 6.7 7.4 ± 5.5 0.120 0.434
 6 Months (Δ) 8.5 ± 9.2 11.2 ± 5.0 0.469 0.436
 1 Year (Δ) 7.2 ± 5.4 13.8 ± 8.6 0.091 0.423
 2 Years (Δ) 3.7 ± 4.0 13.7 ± 4.4 0.001* 0.060
PROM Unilateral cage Bilateral cages OR (95% CI) p-value p-value
VAS back
 6 Weeks 54 (55.1) 160 (50.0) 0.8 (0.4–1.8) 0.615 0.662
 12 Weeks 49 (55.7) 20 (62.5) 1.3 (0.6–3.0) 0.505 0.749
 6 Months 53 (63.9) 19 (67.9) 1.2 (0.5–3.0) 0.701 0.510
 1 Year 15 (62.5) 12 (66.7) 1.2 (0.3–4.3) 0.780 0.226
 2 Years 9 (60.0) 6 (60.0) 1.0 (0.2–5.2) 0.999 0.996
 Overall 73 (73.0) 26 (74.3) 1.1 (0.4–2.6) 0.882 0.208
VAS leg
 6 Weeks 16 (36.4) 9 (30.0) 0.8 (0.3–2.0) 0.570 0.943
 12 Weeks 14 (32.6) 8 (26.7) 0.8 (0.3–2.1) 0.590 0.428
 6 Months 13 (32.5) 5 (18.5) 0.5 (0.1–1.5) 0.210 0.361
 1 Year 9 (37.5) 4 (21.1) 0.4 (0.2–1.8) 0.249 0.020*
 2 Years 4 (33.3) 3 (27.3) 0.8 (0.1–4.5) 0.753 -
 Overall 26 (57.8) 110 (33.3) 0.4 (0.1–0.9) 0.035* 0.077
ODI
 6 Weeks 22 (46.8) 14 (46.7) 1.0 (0.4–2.5) 0.990 0.219
 12 Weeks 26 (59.1) 21 (70.0) 1.6 (0.6–4.3) 0.340 0.892
 6 Months 31 (75.6) 20 (74.1) 0.9 (0.3–2.8) 0.886 0.573
 1 Year 16 (64.0) 14 (73.7) 1.6 (0.4–5.8) 0.496 0.962
 2 Years 9 (69.3) 8 (72.7) 1.2 (0.2–7.0) 0.851 0.544
 Overall 39 (81.3) 27 (79.4) 0.9 (0.3–2.7) 0.836 0.699
SF-12 PCS
 6 Weeks 9 (42.9) 8 (42.1) 1.0 (0.3–3.4) 0.962 0.898
 12 Weeks 11 (57.9) 13 (72.2) 1.9 (0.5–7.5) 0.364 0.835
 6 Months 15 (75.0) 11 (73.3) 0.9 (0.2–4.2) 0.911 0.745
 1 Year 18 (85.7) 15 (79.0) 0.6 (0.1–3.2) 0.576 0.850
 2 Years 12 (75.0) 9 (69.2) 0.8 (0.1–3.8) 0.730 0.796
 Overall 25 (80.7) 22 (84.6) 1.3 (0.3–5.3) 0.695 0.807
PROMIS-PF
 6 Weeks 3 (37.5) 3 (25.0) 0.6 (0.1–3.9) 0.552 0.995
 12 Weeks 3 (42.9) 10 (76.9) 4.4 (0.6–32.1) 0.139 0.878
 6 Months 3 (50.0) 8 (88.9) 8.0 (0.6–110.3) 0.120 0.149
 1 Year 5 (71.4) 10 (90.9) 4.0 (0.3–55.5) 0.301 0.585
 2 Years 3 (50.0) 8 (100) - - -
 Overall 7 (77.8) 14 (87.5) 2.0 (0.2–17.3) 0.529 0.460
Table 1. Patient demographics

Values are presented as mean±standard deviation or number (%).

ASA PS, American Society of Anesthesiologists physical status; CCI, Charlson Comorbidity Index; SD, standard deviation.

p<0.05, statistical significance.

Table 2. Perioperative characteristics

Values are presented as number (%) or mean±standard deviation.

BMP-2, bone morphogenic protein-2.

p<0.05, statistical significance.

Other synthetic bone graft substitute+local bone graft without the use of BMP-2 or iliac crest bone graft.

Arthrodesis status was not able to be assessed for 5 patients due to unavailable postoperative computed tomography scans.

Table 3. Patient-reported outcomes

Values are presented as mean±standard deviation.

PROM, Patient-Reported Outcome Measures; VAS, visual analogue scale; ODI, Oswestry Disability Index; SF-12 PCS, 12-item Short Form health survey physical composite score; PROMIS-PF, Patient-Reported Outcome Measurement Information System physical function.

p<0.05, statistical significance.

p-values calculated using Student t-test to compare mean preoperative scores and mean postoperative improvement between groups.

p-values calculated using 1-way analysis of covariance to compare mean postoperative improvement between groups while accounting for significant covariates.

Table 4. Achievement of MCID

Values are presented as number (%).

MCID, minimum clinically important difference; PROM, Patient-Reported Outcome Measures; OR, odds ratio; CI, confidence interval; VAS, visual analogue scale; ODI, Oswestry Disability Index; SF-12 PCS, 12-item Short Form health survey physical composite score; PROMIS-PF, Patient-Reported Outcome Measurement Information System physical function.

p<0.05, statistical significance.

p-values calculated using logistic regression to assess rates of MCID achievement between groups.

p-values calculated using multiple logistic regression to assess rates of MCID achievement between groups while accounting for significant covariates.